Navigation Links
OxThera coordonne le projet Elimox du 7e PC - 2,19 millions EUR dédiés au développement d'un médicament pour traiter l'hyperoxalurie
Date:9/24/2013

;Recherche au profit de groupes particuliers - Recherche au profit des PME ». Le consortium comprend les 12 partenaires suivants : OxThera AB (Suède), Cobra Biologics Ltd (Royaume-Uni), SymbioPharm GmbH (Allemagne), Ergomed Clinical Research Ltd (Royaume-Uni), Universitätsklinikum Bonn (Allemagne), Hospices civils de Lyon (France), University College London Hospitals NHS Foundation Trust (Royaume-Uni), Galenica AB (Suède), K.A.B.S. Laboratories Inc. (Canada), Medizinisches Versorgumszentrum Institute für Microökologie (Allemagne), TNO (Pays-Bas) et Bio-Images Research Ltd (Royaume-Uni).

À propos de l'hyperoxalurie primaire

L'hyperoxalurie primaire est un trouble génétique autosomal inné rare qui conduit à des élévations marquées des taux d'oxalate endogène dans le plasma et l'urine. Il existe un grand besoin médical insatisfait en termes de traitements efficaces de l'hyperoxalurie. Le seul remède disponible actuellement est la greffe combinée de foie et de rein.

------------------------------------------------

Cette étude a été financée par le septième programme-cadre de l'Union européenne géré par l'Agence exécutive pour la recherche (AER) http://ec.europa.eu/research/rea (FP7/2007-2013) dans le cadre de la convention de subvention no FP7-SME-2013.

Il n'existe aucun accord commercial anticipé susceptible d'imposer des limites à l'exploitation, aux informations ou aux inventions ultérieures générées par ce projet.

Pour tout complément d'information, veuillez contacter :

Elisabeth Lindner, coordinatrice du projet Elimox, tél. : +46-8-660-02-23, e-mail : '/>"/>

SOURCE OxThera
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OxThera stärker patentportfölj för särläkemedel - Primär hyperoxaluri
2. OxThera stärkt sein Patentportfolio für primäre Hyperoxalurie, eine seltene Krankheit
3. OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria
4. Bausch + Lomb soumet une déclaration denregistrement pour un projet doffre publique initiale
5. New Vision Hope For Millions Undergoing Cataract Surgery
6. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
7. Philips ermöglicht noch besseren Zugang zu Behandlungen für häufige Todesursache in den USA durch Bereitstellung seines einmillionsten AED
8. Info Graphic: Middle managers are frozen by information overload, costing companies millions
9. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
10. Millions Around the World to Have Access to Low-Cost HIV Test by 2013
11. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... UPI ), a medical device company that develops, manufactures ... today reported financial results for the fiscal 2015 third ... the Company,s Urgent ®  PC Neuromodulation System grew 14.5% ... compared to $3.9 million in the third quarter of ...
(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...
(Date:1/22/2015)... (NASDAQ: TECH ) announced today that it ... Simple Plex platform through its Proteins Platform division under ... the previously acquired CyPlex instrument platform from CyVek. ... technology which integrates an innovatively designed microfluidic cartridge with ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... Embryonic Stem Cell Lines for Therapeutic ... ... has,become the first to report, and painstakingly document, the cloning of a,human ... an,adult donor. The study was published online today by the journal "Stem,Cells.", ...
... SAN DIEGO, Jan. 17 Vical Incorporated,(Nasdaq: ... $2.1 million cash payment,from AnGes MG, Inc. for ... Melanoma (AIMM) Phase 3 trial., AnGes is ... under a,previously announced collaborative agreement through a scheduled ...
Cached Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 2Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... , FORT WASHINGTON, Pa., Sept. 21 ... by the LACTAID(R) Brand found that 78 percent of African American ... as a way to manage their lactose intolerance. Yet, 48 ... condition keeps them from consuming important nutrients, such as calcium and ...
... , LOS ANGELES, Sept. 21 Aurora Capital ... billion of assets under management, today announced that it has signed ... to acquire its wholly owned subsidiary, Porex Corporation ("Porex" or the ... closing conditions and is expected to close in the fourth quarter ...
... BIRMINGHAM, Ala., Sept. 21 BioCryst Pharmaceuticals, Inc. (Nasdaq: ... proposal (RFP) from the U.S. Department of Health & Human Services ... of critically ill influenza patients under Emergency Use Authorization (EUA). ... minimum and maximum order quantities to be ordered by the government ...
... , , MINNEAPOLIS, Sept. 21 ... and marketer of state-of-the-art cardiac surgery products and services, today ... of the ATS 3f(R) Aortic Bioprosthesis. Based on the ... is a revolutionary next generation stentless pericardial aortic tissue valve ...
... , , VIRGINIA BEACH, Va., Sept. ... city mayor, and Neptune - God of the Sea? The unveiling ... , , A new twist on pin-up ... to 90, recently shed their inhibitions to bare it all (behind strategically ...
... ... potential viewers, will highlight both the DataDeed and Living Will Solutions services on 9/23. ... Preparedness Month. , ... Friedensburg, PA (PRWEB) September 21, 2009 -- Living in Style will feature the highly ...
Cached Medicine News:Health News:New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 2Health News:New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 3Health News:New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 4Health News:Aurora Capital to Acquire Porex Corporation, Leader in Porous Plastic Materials Science 2Health News:Aurora Capital to Acquire Porex Corporation, Leader in Porous Plastic Materials Science 3Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 2Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 3Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 4Health News:ATS Medical Announces Implant Milestone for the ATS 3f Aortic Bioprosthesis Achieved at Columbia University Medical Center 2Health News:ATS Medical Announces Implant Milestone for the ATS 3f Aortic Bioprosthesis Achieved at Columbia University Medical Center 3Health News:Wraps Coming Off 'Nearly-Nude' Senior Calendar in Unique Ceremony 2Health News:Wraps Coming Off 'Nearly-Nude' Senior Calendar in Unique Ceremony 3Health News:Wraps Coming Off 'Nearly-Nude' Senior Calendar in Unique Ceremony 4Health News:TV Spotlight on DataDeed and Living Will Solutions 2
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Model C-10 is a four post cervical orthosis which controls flexion, extension, lateral flexion, rotation, and axial motion. Each post may be individually adjusted in height....
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
... Ezy Wrap® Economy Universal ... foam with synthtic white ... reversed for flexion or ... wash, air dry. 3"H.,Universal ...
Medicine Products: